Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(10):785-795; doi:10.1093/jnci/djh136
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chaudru, V.
Right arrow Articles by Demenais, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudru, V.
Right arrow Articles by Demenais, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

ARTICLE

Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families

Valérie Chaudru, Agnès Chompret, Brigitte Bressac-de Paillerets, Alain Spatz, Marie-Françoise Avril, Florence Demenais

Affiliations of authors: Institut National de la Santé et Recherche Médicale et Université d’Evry, Evry, France (VC, FD); Institut Gustave Roussy, Villejuif, France (AC, BBP, AS, MFA).

Correspondence to: Florence Demenais, MD, INSERM—Université d’Evry, EMI 0006, Tour Evry 2, Génopole, 523 Place des Terrasses de l’Agora, 91034 Evry, France (e-mail: demenais{at}evry.inserm.fr)

Background: Few family studies have investigated the effects of genetic, environmental, and host factors on melanoma risk, and most have been restricted to high-risk families. We assessed the role of these factors on melanoma risk in two types of families: families ascertained through melanoma probands but unselected by family history and melanoma-prone families. Methods: Data on pigmentary traits, nevus phenotypes, exposure to sun, and reactions to sunlight were collected from 295 families unselected by family history and 53 melanoma-prone families. We modeled melanoma risk using a logistic regressive model incorporating the effect of a melanoma-predisposing gene, familial dependence, and potential risk factors (e.g., pigmentary traits, nevus phenotypes, history of sun exposure, skin reactions to sunlight). Maximum-likelihood estimates of the parameters of the regressive model were used to compute odds ratios associated with each risk factor and age-specific melanoma risk depending on the genotype at the melanoma-predisposing gene and the effects of risk factors. All statistical tests were two-sided. Results: In the families unselected by family history, there was statistically significant evidence (P<.001) for a dominant gene, with melanoma risk reaching 0.49 and 0.67 by age 80 years in male and female gene carriers, respectively. Melanoma risk was statistically significantly influenced by total nevi (odds ratio of hazard function [OR] = 5.81, 95% confidence interval [CI] = 3.47 to 8.99), sun exposure (OR = 5.37, 95% CI = 4.44 to 6.36), and sunburn interacting with the gene (OR = 26.31, 95% CI = 7.56 to 99.22 in gene carriers and OR = 1.67, 95% CI = 1.36 to 2.03 in noncarriers). Twenty of the 53 melanoma-prone families had cosegregating mutations in CDKN2A, a gene known to be associated with melanoma. In these 53 families, three risk factors in addition to CDKN2A mutations increased melanoma risk: dysplastic nevi (OR = 2.32, 95% CI = 2.08 to 2.58), total nevi (OR = 1.99, 95% CI = 1.61 to 2.20) and sunburn (OR = 5.16, 95% CI = 4.82 to 5.52). Conclusions: Together, a melanoma-predisposing gene (identified as being CDKN2A in melanoma-prone families), number of nevi and/or dysplastic nevi, and sun-related covariates influence melanoma risk in both families unselected by family history and melanoma-prone families.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
J. C. van Gaal, E. Bastiaannet, M. Schaapveld, R. Otter, J. C. Kluin-Nelemans, E. S. J. M. de Bont, and W. T. A. van der Graaf
Cancer in adolescents and young adults in north Netherlands (1989-2003): increased incidence, stable survival and high incidence of second primary tumours
Ann. Onc., February 1, 2009; 20(2): 365 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A. M Goldstein, M. Chan, M. Harland, N. K Hayward, F. Demenais, D Timothy Bishop, E. Azizi, W. Bergman, G. Bianchi-Scarra, W. Bruno, et al.
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
J. Med. Genet., February 1, 2007; 44(2): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Berwick, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al.
The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1520 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
T. B. H. Buckel, A. M. Goldstein, M. C. Fraser, B. Rogers, and M. A. Tucker
Recent tanning bed use: a risk factor for melanoma.
Arch Dermatol, April 1, 2006; 142(4): 485 - 488.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. M. Goldstein and M. A. Tucker
A Piece of the Melanoma Puzzle
J Natl Cancer Inst, October 19, 2005; 97(20): 1486 - 1487.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Chaudru, K. Laud, M.-F. Avril, A. Miniere, A. Chompret, B. Bressac-de Paillerets, F. Demenais, and The French Familial Melanoma Study Group
Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Cho, B. A. Rosner, D. Feskanich, and G. A. Colditz
Risk Factors and Individual Probabilities of Melanoma for Whites
J. Clin. Oncol., April 20, 2005; 23(12): 2669 - 2675.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.